LBRX

LB Pharmaceuticals

• TipRanks·5d ago

  LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital

• TipRanks·05/13 13:45

  Craig-Hallum Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)

• TipRanks·05/13 11:51

  Analysts Offer Insights on Healthcare Companies: LB Pharmaceuticals, Inc. (LBRX), Agios Pharma (AGIO) and Orchestra BioMed Holdings (OBIO)

• TipRanks·05/13 11:50

  LB Pharmaceuticals, Inc. (LBRX) Gets a Buy from Piper Sandler

• Seeking Alpha·05/12 21:00

  LB Pharmaceuticals Inc GAAP EPS of -$0.67 beats by $0.07

• PUBT·05/12 20:10

  LB Pharmaceuticals Q1 FY26 net loss widens to $19.1 million

• Dow Jones·05/12 20:05

  Press Release: LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update

• NASDAQ·04/28 00:04

  HC Wainwright & Co. Initiates Coverage of LB Pharmaceuticals (LBRX) with Buy Recommendation

• Benzinga·04/27 12:08

  This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

• Dow Jones·04/27 11:26

  LB Pharmaceuticals Initiated at Buy by HC Wainwright & Co.

• Dow Jones·04/27 11:26

  LB Pharmaceuticals Price Target Announced at $45.00/Share by HC Wainwright & Co.

• Benzinga·04/27 11:16

  HC Wainwright & Co. Initiates Coverage On LB Pharmaceuticals with Buy Rating, Announces Price Target of $45

• TipRanks·04/27 10:17

  LB Pharmaceuticals initiated with a Buy at H.C. Wainwright

• Reuters·04/27 10:15

  LB PHARMACEUTICALS INC <LBRX.O>: H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $45

• PUBT·04/23 20:12

  LB Pharmaceuticals announces annual shareholder meeting